These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29471373)

  • 21. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Bari AA; Fasano A; Munhoz RP; Lozano AM
    Expert Rev Neurother; 2015 Oct; 15(10):1151-60. PubMed ID: 26377740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson's disease treated with subthalamic deep brain stimulation.
    Törnqvist AL; Schalén L; Rehncrona S
    Mov Disord; 2005 Apr; 20(4):416-423. PubMed ID: 15593314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic nucleus stimulation effects on single and combined task performance in Parkinson's disease patients: a PET study.
    Atkinson-Clement C; Maillet A; LeBars D; Lavenne F; Redouté J; Krainik A; Pollak P; Thobois S; Pinto S
    Brain Imaging Behav; 2017 Aug; 11(4):1139-1153. PubMed ID: 27704407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Deep-Brain Stimulation on Speech: Perceptual and Acoustic Data.
    Kim Y; Thompson A; Nip ISB
    J Speech Lang Hear Res; 2024 Apr; 67(4):1090-1106. PubMed ID: 38498664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intelligibility of speech in Parkinson's disease relies on anatomically segregated subthalamic beta oscillations.
    Avantaggiato F; Farokhniaee A; Bandini A; Palmisano C; Hanafi I; Pezzoli G; Mazzoni A; Isaias IU
    Neurobiol Dis; 2023 Sep; 185():106239. PubMed ID: 37499882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Hattori M; Kawabata K; Hara K; Ito M; Fujimoto Y; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
    J Neural Transm (Vienna); 2017 Dec; 124(12):1547-1556. PubMed ID: 29098450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Speech Intelligibility During Clinical and Low Frequency.
    Sidtis JJ; Sidtis DVL; Ramdhani R; Tagliati M
    Brain Sci; 2020 Jan; 10(1):. PubMed ID: 31906549
    [No Abstract]   [Full Text] [Related]  

  • 30. Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus.
    Spielman J; Mahler L; Halpern A; Gilley P; Klepitskaya O; Ramig L
    J Commun Disord; 2011; 44(6):688-700. PubMed ID: 21724193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation.
    Tripoliti E; Zrinzo L; Martinez-Torres I; Tisch S; Frost E; Borrell E; Hariz MI; Limousin P
    Mov Disord; 2008 Dec; 23(16):2377-83. PubMed ID: 18785648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominant efficiency of nonregular patterns of subthalamic nucleus deep brain stimulation for Parkinson's disease and obsessive-compulsive disorder in a data-driven computational model.
    Karamintziou SD; Deligiannis NG; Piallat B; Polosan M; Chabardès S; David O; Stathis PG; Tagaris GA; Boviatsis EJ; Sakas DE; Polychronaki GE; Tsirogiannis GL; Nikita KS
    J Neural Eng; 2016 Feb; 13(1):016013. PubMed ID: 26695534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech.
    Fabbri M; Natale F; Artusi CA; Romagnolo A; Bozzali M; Giulietti G; Guimaraes I; Rizzone MG; Accornero A; Lopiano L; Zibetti M
    Parkinsonism Relat Disord; 2021 Jun; 87():130-134. PubMed ID: 34034153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating the effects of subthalamic Nucleus-Deep brain stimulation on the voice quality.
    Sarac ET; Yilmaz A; Aydinli FE; Yildizgoren MT; Okuyucu EE; Okuyucu S; Akakin A
    Somatosens Mot Res; 2020 Sep; 37(3):157-164. PubMed ID: 32397796
    [No Abstract]   [Full Text] [Related]  

  • 36. Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation.
    Sandström L; Hägglund P; Johansson L; Blomstedt P; Karlsson F
    Brain Behav; 2015 Oct; 5(10):e00394. PubMed ID: 26516614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysphonia and Dysarthria in People With Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation: Effect of Frequency Modulation.
    Morello ANDC; Beber BC; Fagundes VC; Cielo CA; Rieder CRM
    J Voice; 2020 May; 34(3):477-484. PubMed ID: 30454944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease.
    Moreau C; Defebvre L; Destée A; Bleuse S; Clement F; Blatt JL; Krystkowiak P; Devos D
    Neurology; 2008 Jul; 71(2):80-4. PubMed ID: 18420482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No differential effects of subthalamic nucleus vs. globus pallidus deep brain stimulation in Parkinson's disease: Speech acoustic and perceptual findings.
    van Brenk F; Stipancic KL; Rohl AH; Corcos DM; Tjaden K; Greenlee JDW
    IBRO Neurosci Rep; 2024 Jun; 16():361-367. PubMed ID: 38425546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
    Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
    Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.